FAQ

mebeverine

Known as: 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) veratrate, duspatalin, spasmotalin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1963-2017
051019632017

Related topics

Related topics

4 relations

Broader (3)

AnticonvulsantsParasympatholyticsPhenethylamines

Narrower (1)

Mebeverine hydrochloride

Related mentions per year

Related mentions per year

1940-2018
19401960198020002020
mebeverine
Anticonvulsants
Phenethylamines
Parasympatholytics
Mebeverine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
BACKGROUND The 5-HT(3) receptor antagonists are known to be effective for the treatment of diarrhea-predominant irritable bowel… (More)
Is this relevant?
2009
2009
pH-Sensitive Mebeverine Microspheres for Colon Delivery
Mebeverine hydrochloride is known to suffer from extensive first pass effect. In an attempt to improve its oral bioavailability… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2006
2006
Investigative implications of the instability and metabolism of mebeverine.
The anti-spasmodic drug mebeverine is used in the treatment of irritable bowel syndrome. It has been found to be unstable and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
Is this relevant?
2005
2005
Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial.
OBJECTIVE To assess the efficacy of cognitive behaviour therapy delivered in primary care for treating irritable bowel syndrome… (More)
Is this relevant?
2004
2004
Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study.
BACKGROUND Irritable bowel syndrome (IBS) is a functional disorder affecting the quality of life of patients. In the Netherlands… (More)
Is this relevant?
2002
2002
Identification of mebeverine acid as the main circulating metabolite of mebeverine in man.
The intestinal spasmolytic drug mebeverine is known to undergo fast in vivo enzymatic hydrolysis into mebeverine alcohol and… (More)
Is this relevant?
1999
1999
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients.
BACKGROUND Irritable bowel syndrome is one of the most common gastrointestinal disorders, yet no therapy convincingly controls… (More)
Is this relevant?
1996
1996
Mebeverine alters small bowel motility in irritable bowel syndrome.
BACKGROUND AND AIM Despite its widespread use in irritable bowel syndrome (IBS), limited clinical data exist on the effects of… (More)
Is this relevant?
1991
1991
Facile hydrolysis of mebeverine in vitro and in vivo: negligible circulating concentrations of the drug after oral administration.
The HPLC methods for the determination of plasma concentrations of the antispasmodic agent mebeverine (0.01-10 micrograms/mL) and… (More)
Is this relevant?
1986
1986
Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.
There is no generally accepted treatment in the irritable bowel syndrome (IBS), probably because of a lack of convincing… (More)
Is this relevant?